About CHIGENOVO
CHIGENOVO is a company based in China founded in 2016. CHIGENOVO has raised $26.45 million across 3 funding rounds from investors including Kunlun Capital, Gimpo Investment and Yingke Capital. CHIGENOVO offers products and services including Gene Therapy Drugs and Gene Diagnosis Services.
- Headquarter Changping District, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name 北京中因科技有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.45 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Kunlun Capital
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CHIGENOVO
CHIGENOVO offers a comprehensive portfolio of products and services, including Gene Therapy Drugs and Gene Diagnosis Services.
Gene therapy drugs for hereditary eye diseases are developed and evaluated.
Precise genetic diagnosis for eye diseases is offered through sequencing and analysis.
Funding Insights of CHIGENOVO
CHIGENOVO has successfully raised a total of $26.45M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CHIGENOVO
CHIGENOVO has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kunlun Capital, Gimpo Investment and Yingke Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in technology companies are managed by Kunlun Capital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CHIGENOVO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CHIGENOVO
Investment portfolio details for CHIGENOVO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CHIGENOVO
Detailed financials for CHIGENOVO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chigenovo Comparisons
Peer comparison for CHIGENOVO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CHIGENOVO
Detailed competitors of CHIGENOVO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chigenovo
Complete news archive for CHIGENOVO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHIGENOVO
CHIGENOVO was founded in 2016 and raised its 1st funding round 5 years after it was founded.
CHIGENOVO is headquartered in China. It is registered at Beijing, China.
CHIGENOVO is a funded company, having raised a total of $26.45M across 3 funding rounds to date.
CHIGENOVO was founded in 2016 and is located in Changping District, China. Operations are centered in the biotechnology sector, where gene therapy drugs for inherited eye diseases are developed alongside genetic diagnosis services. Focus is placed on high-tech advancements to address these conditions through innovative therapeutic and diagnostic approaches. The company operates as a specialized enterprise in this niche.
CHIGENOVO offers Gene Therapy Drugs and Gene Diagnosis Services.
CHIGENOVO has 7 investors. Key investors include Kunlun Capital, Gimpo Investment, Yingke Capital, Huayi Capital, and Junci Investment.